Over a trial period of 31 days, participants treated with Y14 peptide experienced a weight reduction of 2.9 to 3.6 kilograms, with a 38% to 55% reduction in food intake compared to the placebo group
GLP-1 weight management starts at $215 per month (semaglutide) or $375 per month (tirzepatide)
succinate dehydrogenase, SDH, and Complex IV
A 1200-calorie day with very little protein is not the same as a 1400-calorie day with protein spread across meals
Many point to the interplay between weight loss and its impact on fertility, as well as the off-label use of GLP-1 RAs to manage polycystic ovarian syndrome (PCOS)
This unique mechanism amplifies metabolic benefits, leading to superior glycemic control, significant weight reduction, and cardiovascular protection